245 related articles for article (PubMed ID: 19435196)
1. [Risk of locally-advanced recurrences of breast cancer following organ-saving surgery].
Gurbanov SS; Matsko DE; Kanaev SV; Semiglazov VF
Vopr Onkol; 2009; 55(1):33-7. PubMed ID: 19435196
[TBL] [Abstract][Full Text] [Related]
2. Frequency of locoregional and axillary recurrences among patients following breast cancer operations.
Bakos I; Almássy S
Acta Chir Hung; 1997; 36(1-4):9-10. PubMed ID: 9408268
[TBL] [Abstract][Full Text] [Related]
3. [Perspectives in use of surgery for disintegrating breast tumor].
Topuzov EE; Sadigova SN; Lemekhov VG; Aristov RL; Danilov AG; Bozhok AA; Kasianova MN; Klimov NA; Topuzov RE
Vopr Onkol; 2011; 57(4):502-4. PubMed ID: 22191242
[TBL] [Abstract][Full Text] [Related]
4. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of local recurrence after breast preserving surgery].
Garami Z; Szluha K; Kósa C; Fülöp B; Lukács G
Magy Seb; 2006 Jun; 59(3):179-83. PubMed ID: 16937793
[TBL] [Abstract][Full Text] [Related]
6. [Sparing and organ-saving operations in breast cancer].
Semiglazov VF; Chagunava OL
Vopr Onkol; 1990; 36(5):535-9. PubMed ID: 2378074
[TBL] [Abstract][Full Text] [Related]
7. [Indications for adjuvant radiotherapy in primary breast-saving and ablative treatment of breast cancer].
Bahnsen J
Gynakologe; 1994 Apr; 27(2):64-9. PubMed ID: 8039744
[No Abstract] [Full Text] [Related]
8. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
Jobsen JJ; van der Palen J; Ong F
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450
[TBL] [Abstract][Full Text] [Related]
9. Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy.
Yiu CC; Loo WT; Lam CK; Chow LW
Chin Med J (Engl); 2009 Apr; 122(8):900-5. PubMed ID: 19493411
[TBL] [Abstract][Full Text] [Related]
10. [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)].
Roman LD; Fedorov KA; Krasnozhon DA
Vopr Onkol; 2004; 50(1):99-100. PubMed ID: 15088531
[TBL] [Abstract][Full Text] [Related]
11. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
[TBL] [Abstract][Full Text] [Related]
12. [Histological margin and residual disease assessment for breast carcinoma].
Sigal-Zafrani B; Fourquet A; Vincent-Salomon A; Fréneaux P; Génin P; Rosty C; Sastre-Garau X
Cancer Radiother; 2003 Nov; 7 Suppl 1():120s-123s. PubMed ID: 15124553
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of determination of the presence and histologic grade of the intraductal component in invasive ductal carcinoma of the breast after conservative treatment].
Sarcević B; Separović R; Separović V; Oresić V; Nola N; Vrdoljak M; Marić M; Stajcer-Stitić V; Milas I; Kruslin B
Lijec Vjesn; 1998; 120(1-2):4-7. PubMed ID: 9650477
[TBL] [Abstract][Full Text] [Related]
14. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K
Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332
[TBL] [Abstract][Full Text] [Related]
15. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
16. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of local recurrence after breast-conserving therapy in young patients.
Baltoyiannis G; Roukos DH; Fatouros M
Radiother Oncol; 2008 Feb; 86(2):286-7; author reply 287-8. PubMed ID: 17963905
[No Abstract] [Full Text] [Related]
18. [Manifestation, therapy and follow-up of locoregional breast carcinoma recurrence].
Menke H; Schreckenberger C; Restel J; Olbrisch RR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():108-10. PubMed ID: 9101786
[TBL] [Abstract][Full Text] [Related]
19. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
[No Abstract] [Full Text] [Related]
20. Tubular carcinoma of the breast: results of a large contemporary series.
Javid SH; Smith BL; Mayer E; Bellon J; Murphy CD; Lipsitz S; Golshan M
Am J Surg; 2009 May; 197(5):674-7. PubMed ID: 18789411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
